PROX1, a Key Mediator of the Anti-Proliferative Effect of Rapamycin on Hepatocellular Carcinoma Cells

The MTOR signal is known to be activated in various cancer cells including hepatocellular carcinoma (HCC) cells. Rapamycin, a specific inhibitor of MTOR, has been widely used as an immunosuppressant in organ transplant patients, and its clinical application has been recently expanded to cancer thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Sora, Ban, Kiwon, Hong, Young-Kwon, Sung, Jung-Suk, Choi, Inho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834064/
https://www.ncbi.nlm.nih.gov/pubmed/35159256
http://dx.doi.org/10.3390/cells11030446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834064/
https://www.ncbi.nlm.nih.gov/pubmed/35159256
http://dx.doi.org/10.3390/cells11030446

Ejemplares similares